Latest Biotechnology, Pharmaceutical and Healthcare News - Page: 4 from Reuters

Beiersdorf shares rise on P&G bid speculation

FRANKFURT, May 16 (Reuters) - Shares in Nivea-maker Beiersdorf rose on Thursday on market speculation that majority shareholder Maxingvest was selling half of its stake to U.S. rival Procter & Gamble, talk that was dismissed by a source close to the...

Chief executives and the itch to quit

LONDON, May 16 (Reuters) - On approaching his 60th birthday this year, long-serving Tullow Oil boss Aidan Heavey told staff he felt "like two 30 year-olds".

China steps up inspection of meat trade after fake lamb scandal

BEIJING (Reuters) - China has begun a crackdown on the sales of fake, diseased and tainted meat products after a series of scandals that have further dented public confidence in the food industry, the official Xinhua news agency said on Thursday.

Hikma expects revenue to rise 13 pct in 2013

May 16 (Reuters) - Hikma Pharmaceuticals Plc raised its full-year revenue forecast, saying its generic antibiotic doxycycline was generating revenue ahead of its expectations.

German stocks - Factors to watch on May 16

FRANKFURT, May 16 (Reuters) - The DAX top-30 index looked set to open 0.3 percent lower on Thursday, according to premarket data from brokerage Lang & Schwarz at 0636 GMT.

BRIEF-Hikma Pharmaceutical expects group revenue to grow by around 13% in 2013

LONDON, May 16 (Reuters) - Hikma Pharmaceuticals PLC : * Hikma pharmaceutical - interim management statement * Branded and injectables businesses are on track to meet our current FY

UPDATE 2-NORDIC STOCKS - Factors to watch on May 16

HELSINKI, May 16 (Reuters) - The following stocks may be affected by newspaper reports and other factors on Thursday:

Swiss stocks - Factors to watch on May 16

ZURICH, May 16 (Reuters) - Swiss stocks are expected to open slightly weaker on Thursday, consolidating after a big rally on Wednesday fuelled by a weaker franc as other European markets also steadied.

AstraZeneca accelerates cancer drug testing

* Final-stage studies on olaparib, selumetinib start in H2

NORDIC STOCKS - Factors to watch on May 16

HELSINKI, May 16 (Reuters) - The following stocks may be affected by newspaper reports and other factors on Thursday:

INSIGHT-Dimon has big say over who serves on JPMorgan board

May 16 (Reuters) - For years, JPMorgan Chase & Co Chairman and CEO Jamie Dimon and other executives have hand-picked new directors, in a practice that is now unusual for a major U.S. bank.

Singapore commodity firms crimp spending in challenging times

SINGAPORE, May 16 (Reuters) - Singapore-listed commodity firms Olam International Ltd, Noble Group Ltd and Wilmar International Ltd are cutting capital expenditure, making more selective acquisitions and seeking partnerships to weather volatile marke...

Medical weed could jinx recreational dope market in Washington state

OLYMPIA, Washington (Reuters) - Key officials helping to create Washington state's potentially lucrative recreational pot market say its success may hinge on preventing consumers from choosing to get high on readily available medical cannabis because...

Thailand - Market factors to watch on May 16

BANGKOK, May 16 (Reuters) - Following is some company-related and market news that could affect the local market. MARKETS 0112 GMT AT INSTRUMENT LAST % CHG NET CHG S&P 500 1658.78 0.51 8.44 USD/JPY 102.13 -0.10 -0.10 10-YR US TSY 98

MRI scans could make baby autopsies more acceptable

LONDON (Reuters) - Bereaved parents who do not want to see their dead babies go through a conventional autopsy could in future be offered a less invasive option which uses magnetic resonance imaging and blood tests to establish the cause of death.

SEC says new settlements end 'Golden Goose' insider trading case

May 15 (Reuters) - The U.S. Securities and Exchange Commission on Wednesday said it has reached settlements with the last two defendants in an insider trading probe known as the "Golden Goose" case, which had been based on secrets stolen from an exec...

U.S. advisory on mercury in fish tied up at health department

WASHINGTON (Reuters) - Updated federal advice on mercury levels in fish appears to have stalled within the U.S. department of health, frustrating scientists and advocacy groups who argue that exposure to mercury may be dangerous at lower levels than...

WHO reports first patient-to-nurse spread of new SARS-like virus

LONDON (Reuters) - Two health workers in Saudi Arabia have become infected with a potentially fatal new SARS-like virus after catching it from patients in their care - the first evidence of such transmission within a hospital, the World Health Organi...

UPDATE 1-Monsanto tests planting platform, eyes new microbial business

ST. LOUIS, May 15 (Reuters) - Monsanto Co, the world's largest seed company, is developing two new platforms that diverge from its core business and are seen as potential key long-term growth drivers, according to top Monsanto executives.

US Senate confirms Tavenner as Medicare/Medicaid chief

WASHINGTON (Reuters) - The U.S. Senate on Wednesday confirmed Marilyn Tavenner, a former nurse and hospital company executive, as the first full-fledged administrator for the Medicare and Medicaid healthcare programs since 2006.

UPDATE 2-US Senate confirms Tavenner as Medicare/Medicaid chief

WASHINGTON, May 15 (Reuters) - The U.S. Senate on Wednesday confirmed Marilyn Tavenner, a former nurse and hospital company executive, as the first full-fledged administrator for the Medicare and Medicaid healthcare programs since 2006.

Bristol melanoma drug combo marks new advance in immunotherapy

CHICAGO (Reuters) - Melanoma patients treated with two Bristol-Myers Squibb drugs fared much better than those who received either of the medications individually, a new advance for treatments that harness the body's immune system to fight cancer....

Data shows new Roche leukemia drug may improve on Rituxan

(Reuters) - An experimental leukemia treatment that Roche Holding AG hopes will improve upon its best-selling cancer drug Rituxan delayed disease progression twice as long as chemotherapy, according to preliminary trial data released on Wednesday....

U.S. advisory on mercury in fish tied up at health dept

WASHINGTON, May 15 (Reuters) - Updated federal advice on mercury levels in fish appears to have stalled within the U.S. department of health, frustrating scientists and advocacy groups who argue that exposure to mercury may be dangerous at lower leve...

Experimental Gilead drug effective in early-stage leukemia trial

(Reuters) - An experimental drug from Gilead Sciences Inc shrank tumors in half of leukemia patients whose cancer had returned, according to an early-stage trial that represents a new foray into oncology by the world's biggest seller of HIV medicatio...